The mechanisms underlying osimertinib resistance, which may be associated with tumor evolution, clonal heterogeneity, and selection pressure, can be categorized into two types: EGFR-dependent (on-target) and EGFR-independent (off-target) mechanisms (9). Here, EGFR is linked to neoplasm.